Skip to main content
Loading Nifty 50, Nifty Bank, and Sensex…

Sun Pharmaceutical Industries Limited

SUNPHARMA · Corporate filings

Sun Pharmaceutical Industries Limited

SUNPHARMA · NSE · Healthcare
₹1,885.00
-0.91%
As of 12 Nov 2026

Sun Pharmaceutical Industries Limited (SUNPHARMA) is listed on NSE in the Healthcare sector. It last traded at ₹1,885.00, down 0.91% on the session. Its 52-week range is ₹1,583.70 to ₹2,046.90.

Research output is rule-based and informational only. It is not investment advice.
Analytics for SUNPHARMA are not available yet. Technicals, fundamentals, peer ranking and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report

Stock market charts for Sun Pharmaceutical Industries Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.

Loading financial charts...

Results Change Summary quarter-on-quarter and year-on-year filing evidence

Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.

Financial Results figures in ₹ crore, except EPS/%

Loading…

Relative Returns stock, sector, and exchange benchmarks

Loading…

CAN SLIM William O'Neil's growth-stock criteria

Loading…

Latest Shareholding Pattern promoter, FII, DII, public and institution trend

Loading shareholding pattern...

Corporate Governance SEBI integrated governance filing

Loading governance disclosure...

Announcements
Market activity
Short selling - 5 shares
Announcement
Market activity
Short selling - 70 shares
Announcement
Announcement
Market activity
Short selling - 751 shares
Announcement
Announcement
Announcement
Announcement
Announcement
Market activity
Short selling - 21 shares
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights Full history
Dividend Dividend - Rs 5 Per Share Dividend - Rs 5 Per Share Ex-date: 07 Jul 2026
Dividend Interim Dividend - Rs 11 Per Share Interim Dividend - Rs 11 Per Share Ex-date: 05 Feb 2026
Dividend Dividend - Rs 5.50 Per Share Dividend - Rs 5.50 Per Share Ex-date: 07 Jul 2025
Dividend Interim Dividend - Rs 10.50 Per Share Interim Dividend - Rs 10.50 Per Share Ex-date: 06 Feb 2025
Dividend Dividend - Rs 5 Per Share Dividend - Rs 5 Per Share Ex-date: 12 Jul 2024
Dividend Interim Dividend - Rs 8.50 Per Share Interim Dividend - Rs 8.50 Per Share Ex-date: 09 Feb 2024
Dividend Dividend - Rs 4 Per Share Dividend - Rs 4 Per Share Ex-date: 28 Jul 2023
Dividend Interim Dividend - Rs 7.50 Per Share Interim Dividend - Rs 7.50 Per Share Ex-date: 08 Feb 2023
Dividend Dividend - Rs 3 Per Share Dividend - Rs 3 Per Share Ex-date: 19 Aug 2022
Dividend Interim Dividend - Rs 7 Per Share Interim Dividend - Rs 7 Per Share Ex-date: 09 Feb 2022
Dividend Annual General Meeting/Dividend - Rs 2 Per Share Annual General Meeting/Dividend - Rs 2 Per Share Ex-date: 23 Aug 2021
Dividend Interim Dividend - Rs 5.50 Per Share Interim Dividend - Rs 5.50 Per Share Ex-date: 09 Feb 2021
Dividend Annual General Meeting/Dividend - Re 1 Per Share Annual General Meeting/Dividend - Re 1 Per Share Ex-date: 19 Aug 2020
Dividend Interim Dividend - Rs 3 Per Share Interim Dividend - Rs 3 Per Share Ex-date: 17 Feb 2020
Dividend Annual General Meeting/Dividend - Rs 2.75 Per Share Annual General Meeting/Dividend - Rs 2.75 Per Share Ex-date: 20 Aug 2019
Dividend Annual General Meeting/Dividend Rs 2 Per Share Annual General Meeting/Dividend Rs 2 Per Share Ex-date: 17 Sep 2018
Dividend Annual General Meeting/Dividend - Rs 3.50 Per Share Annual General Meeting/Dividend - Rs 3.50 Per Share Ex-date: 18 Sep 2017
Dividend Annual General Meeting/Dividend Re 1/- Per Share Annual General Meeting/Dividend Re 1/- Per Share Ex-date: 08 Sep 2016
Buyback Buy Back Buy Back Ex-date: 14 Jul 2016
Dividend Annual General Meeting/ Dividend - Rs 3/- Per Share Annual General Meeting/ Dividend - Rs 3/- Per Share Ex-date: 21 Oct 2015
Board Meetings
30 Oct 2026
Unaudited Financial Results for the quarter and half year ended 30 September 2026
12 Oct 2026
Outcome of the Board Meeting held on 12 October 2026
31 Jul 2026
Unaudited Standalone and Consolidated Financial Results for Q1 of FY 2026-27